https://qrpharma.com/ 2024-12-26T13:12:33+00:00 https://qrpharma.com/press-room/ 2024-12-25T10:46:37+00:00 https://qrpharma.com/leadership/ 2025-01-05T18:31:35+00:00 https://qrpharma.com/thank-you/ 2024-12-25T09:07:45+00:00 https://qrpharma.com/terms-of-use/ 2024-12-27T00:20:58+00:00 https://qrpharma.com/subscription/ 2024-12-25T09:07:45+00:00 https://qrpharma.com/submit-a-post/ 2024-12-27T08:52:21+00:00 https://qrpharma.com/registration/ 2024-12-27T00:23:03+00:00 https://qrpharma.com/privacy-policy/ 2024-12-28T06:57:27+00:00 https://qrpharma.com/payment/ 2024-12-25T09:07:45+00:00 https://qrpharma.com/news-articles/ 2024-12-25T12:26:14+00:00 https://qrpharma.com/login/ 2024-12-27T00:22:35+00:00 https://qrpharma.com/edit/ 2024-12-25T09:07:45+00:00 https://qrpharma.com/dashboard/ 2024-12-25T10:24:51+00:00 https://qrpharma.com/site-map/ 2024-12-27T00:25:27+00:00 https://qrpharma.com/investors/ 2025-01-05T17:14:54+00:00 https://qrpharma.com/posiphen-and-analogs-experimental-alzheimer-agents-that-reduce-amyloid-s-peptide-by-lowering-amyloid-precursor-protein-levels-in-culture-and-in-vivo/ 2024-12-25T10:06:16+00:00 https://qrpharma.com/qr-pharma-inc-presents/ 2024-12-25T12:29:20+00:00 https://qrpharma.com/william-mobley/ 2024-12-25T09:17:30+00:00 https://qrpharma.com/sidney-strickland/ 2024-12-25T09:44:04+00:00 https://qrpharma.com/rudolph-tanzi/ 2024-12-25T09:46:23+00:00 https://qrpharma.com/rich-fitzgerald/ 2024-12-25T09:47:22+00:00 https://qrpharma.com/posiphen/ 2024-12-25T10:08:48+00:00 https://qrpharma.com/peter-davies/ 2024-12-25T10:10:36+00:00 https://qrpharma.com/michael-m-b-hoffman/ 2024-12-25T10:12:46+00:00 https://qrpharma.com/mary-sano/ 2024-12-27T08:50:12+00:00 https://qrpharma.com/mark-white-2/ 2024-12-27T00:21:51+00:00 https://qrpharma.com/maria-l-maccecchini/ 2024-12-25T10:17:14+00:00 https://qrpharma.com/jeffrey-l-cummings/ 2024-12-25T10:18:36+00:00 https://qrpharma.com/gregory-petsko/ 2024-12-25T10:22:11+00:00 https://qrpharma.com/eugene-cooper/ 2024-12-25T10:22:43+00:00 https://qrpharma.com/debomoy-lahiri/ 2024-12-25T10:23:56+00:00 https://qrpharma.com/claudine-e-bruck/ 2024-12-25T10:30:54+00:00 https://qrpharma.com/careers/ 2024-12-25T10:34:07+00:00 https://qrpharma.com/bob-whelan/ 2024-12-25T10:35:02+00:00 https://qrpharma.com/contact/ 2024-12-27T08:51:23+00:00 https://qrpharma.com/clinical/ 2025-01-05T17:26:07+00:00 https://qrpharma.com/innovation/ 2025-01-05T17:18:57+00:00 https://qrpharma.com/about-us/ 2025-03-26T09:57:56+00:00 https://qrpharma.com/disease-focus/ 2025-01-05T17:17:10+00:00 https://qrpharma.com/targeting-alzheimers-and-other-neurodegenerative-diseases-via-a-novel-mechanism-of-action/ 2024-12-25T11:09:47+00:00 https://qrpharma.com/targeting-alzheimers-with-novel-therapuetics/ 2024-12-25T10:47:23+00:00 https://qrpharma.com/healthcare-businesswomens-association-women-in-science-winter-2011-2/ 2024-12-25T07:31:27+00:00 https://qrpharma.com/maria-maccecchini-to-receive-2011-iris-newmann-award-november-16-2011/ 2024-12-25T12:28:08+00:00 https://qrpharma.com/maria-maccecchini-president-and-ceo-of-qr-pharma-inc-to-serve-on-panel-with-nobel-laureate-phillip-sharp-at-chemical-heritage-foundation-event/ 2024-12-25T07:30:01+00:00 https://qrpharma.com/paul-blake-hal-broderson-and-franz-hefti-join-qr-pharma-board-company-taps-regions-proven-experts-in-growing-successful-companies/ 2024-12-25T12:30:37+00:00 https://qrpharma.com/oral-posiphen-treatment-lowers-as42-in-mouse-brain/ 2024-12-25T07:29:03+00:00 https://qrpharma.com/new-scientific-advisory-board/ 2024-12-28T10:27:32+00:00 https://qrpharma.com/new-data-on-posiphen-in-traumatic-brain-injury/ 2024-12-25T07:27:41+00:00 https://qrpharma.com/neuroscience-network-is-alzheimers-disease-close-to-being-cured-may-11-2010/ 2024-12-25T07:27:05+00:00 https://qrpharma.com/medcitynews-serial-entrepreneur-to-receive-award-october-31-2011/ 2024-12-25T07:26:29+00:00 https://qrpharma.com/mechanism-of-action-of-posiphen-from-model-to-human-2/ 2024-12-25T08:01:33+00:00 https://qrpharma.com/presentation-at-newsmakers/ 2024-12-25T12:29:08+00:00 https://qrpharma.com/posiphen-treatment-is-able-to-reduce-app-levels-in-ta65dn-mouse-model-of-down-syndrome/ 2024-12-25T12:26:13+00:00 https://qrpharma.com/posiphen-technical-summary/ 2024-12-25T08:09:09+00:00 https://qrpharma.com/posiphen-restores-brain-function-cognition-and-memory-in-transgenic-alzheimer-mice/ 2024-12-25T12:33:39+00:00 https://qrpharma.com/posiphen-human-clinical-data/ 2024-12-25T08:12:00+00:00 https://qrpharma.com/posiphen-human-biomarker-data/ 2024-12-25T08:19:26+00:00 https://qrpharma.com/biocentury-qr-power-of-positivity-may-30-2011/ 2024-12-25T08:22:12+00:00 https://qrpharma.com/ben-franklin-technology-partners-invests-110000-in-qr-pharma/ 2024-12-26T23:49:39+00:00 https://qrpharma.com/philadelphia-business-journal-qr-pharma-to-start-trial-on-alzheimers-drug-february-10-2010/ 2024-12-25T07:21:52+00:00 https://qrpharma.com/philadelphia-business-journal-maccecchini-back-in-ceo-seat-at-qr-pharma-november-28-2008-2/ 2024-12-25T07:21:20+00:00 https://qrpharma.com/peter-davies-the-2015-recipient-of-the-potamkin-award-joins-the-scientific-advisory-board-of-qr-pharma/ 2024-12-25T12:30:37+00:00 https://qrpharma.com/we-need-volunteers-to-test-novel-approaches-and-help-cure-alzheimers-disease/ 2024-12-25T11:04:11+00:00 https://qrpharma.com/wallstreet-journal-serial-entrepreneur-to-receive-award-november-1-2011/ 2024-12-25T12:28:21+00:00 https://qrpharma.com/u-s-1-has-alzheimers-disease-met-its-match-may-5-2010-2/ 2024-12-25T07:57:22+00:00 https://qrpharma.com/torreypines-therapeutics-licenses-posiphen-bisnorcymcerine-and-phenserine-to-qr-pharma/ 2024-12-25T07:05:12+00:00 https://qrpharma.com/qr-pharma-to-present-at-the-alzheimers-association-international-conference/ 2024-12-25T12:30:37+00:00 https://qrpharma.com/the-michael-j-fox-foundation-for-parkinsons-research-therapeutics-development-initiative/ 2024-12-25T12:26:13+00:00 https://qrpharma.com/qr-pharma-to-present-at-11th-annual-world-pharma-congress/ 2024-12-25T12:30:37+00:00 https://qrpharma.com/qr-pharma-to-present-a-paper-on-clinical-development-of-its-lead-compound-posiphen-in-alzheimers-disease/ 2024-12-25T07:45:51+00:00 https://qrpharma.com/ben-franklin-technology-partners-qr-pharma-focuses-on-treatments-for-alzheimeri%c2%bds-and-dementia-related-to-down-syndrome-may-2010/ 2024-12-25T12:27:39+00:00 https://qrpharma.com/qr-pharma-reports-results-from-sbir-grant-by-nianih-to-study-posiphen-and-metabolites-in-various-models/ 2024-12-25T12:30:37+00:00 https://qrpharma.com/qr-pharma-receives-us-patent-8691864-to-treat-dementia/ 2024-12-25T12:30:37+00:00 https://qrpharma.com/qr-pharma-receives-seed-investment-from-ben-franklin-technology-partners-for-further-development-of-clinical-stage-compounds-to-treat-alzheimers-disease/ 2024-12-25T12:30:36+00:00 https://qrpharma.com/qr-pharma-raises-800000-of-series-a-preferred-stock/ 2024-12-25T12:30:36+00:00 https://qrpharma.com/qr-pharma-presents-at-the-university-of-pennsylvania-convergence-of-factors-leading-to-neurodegenerative-disorders/ 2024-12-25T12:30:36+00:00 https://qrpharma.com/qr-pharma-issues-5-7-m-of-series-a-preferred-stock/ 2024-12-25T12:30:36+00:00 https://qrpharma.com/qr-pharma-inc-to-participate-in-harvards-neuro-advance-boston-conference/ 2024-12-25T12:27:27+00:00 https://qrpharma.com/qr-pharma-inc-presents-new-data-on-posiphen-in-alzheimers-and-parkinsons-disease-at-the-13th-adpd-international-conference/ 2024-12-25T12:03:30+00:00 https://qrpharma.com/qr-pharma-funding/ 2024-12-25T12:30:36+00:00 https://qrpharma.com/qr-pharma-begins-collaboration-on-posiphen-and-huntingtons-disease/ 2024-12-25T12:30:36+00:00 https://qrpharma.com/qr-pharma-awarded-funding-by-michael-j-fox-foundation-to-test-posiphen-as-a-treatment-for-parkinsons-disease/ 2024-12-25T12:30:36+00:00 https://qrpharma.com/qr-pharma-announces-the-start-of-a-phase-i-clinical-study-for-bisnorcymserine-first-human-trial-of-compound-discovered-at-nih-may-treat-alzheimers-disease/ 2024-12-25T12:30:36+00:00 https://qrpharma.com/qr-pharma-announces-publication-on-posiphen-clinical-trials-showing-promise-for-alzheimers-patients/ 2024-12-25T12:30:36+00:00 https://qrpharma.com/qr-pharma-announces-the-appointment-of-new-chairman-and-new-board-member/ 2024-12-25T12:30:36+00:00